IM Cannabis Acquires Israel s Largest Retail and Online Pharmacy Business from Panaxia, Creating a Vertically Integrated Global Platform for the IMC Brand
ACCESSWIRE
With Israel
1 per Month), Panaxia s Online Platform to Support Patient Base Expansion
Acquisition Broadens IMC s Patient Offering in Israel, Facilitates Stronger Direct Patient Relationships and Enables the Company to Grow its IMC Brand Awareness
Offers Additional Opportunity to Generate Revenue and Margin on Third-Party Products and is Synergistic with IMC s Premium and Super-Premium Canadian Indoor Production Portfolio
Adds Key Storage, Distribution and Delivery Capabilities, Plus Established Call Center to Support Growth as Israeli Market Prepares for Potential Adult-Use Recreational Cannabis Legalization
IM Cannabis Corp.: IM Cannabis Acquires Israel s Largest Retail and Online Pharmacy Business from Panaxia, Creating a Vertically Integrated Global Platform for the IMC Brand
1 per Month), Panaxia s Online Platform to Support Patient Base Expansion
Acquisition Broadens IMC s Patient Offering in Israel, Facilitates Stronger Direct Patient Relationships and Enables the Company to Grow its IMC Brand Awareness
Offers Additional Opportunity to Generate Revenue and Margin on Third-Party Products and is Synergistic with IMC s Premium and Super-Premium Canadian Indoor Production Portfolio
Adds Key Storage, Distribution and Delivery Capabilities, Plus Established Call Center to Support Growth as Israeli Market Prepares for Potential Adult-Use Recreational Cannabis Legalization
PharmaCielo Makes Initial Shipments to two Brazilian Customers
News provided by
Share this article
1 early integration into the supply chain.
Shipments followed an audit by the Phyto-Therapeutics customer, that confirmed PharmaCielo s compliance with Brazilian GMP standards.
TORONTO, and RIONEGRO, Colombia, April 26, 2021 /CNW/ - PharmaCielo Ltd. ( PharmaCielo or the Company ) (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia s premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced that it has completed initial shipments to two customers in Brazil following an audit to confirm PharmaCielo s compliance with Brazilian Good Manufacturing Practices ( GMP ) standards. The first shipment recently arrived at one of Brazil s largest Phyto-Therapeutics companies. This customer intends to integrate PharmaCielo s APIs into custom formulations for current and future product registry and sale in the local
IM Cannabis Corp.: IM Cannabis Reports Fiscal 2020 Results; Provides Preliminary Q1 Results and Q2 Outlook
1; FY 2020: revenues of $15.9 million and gross margin of 55%
1
.
Preliminary unaudited Q1 2021 revenues expected to be in the range of $8.5 - $9.0 million; gross margin expected to be in the range of 50% to 55%.
Q2 2021 revenues expected to be in the range of $17 million - $19 million from continued growth in Israel, resumption of product shipments and growth of revenue in Germany, and inclusion of Trichome operations in the Company s financial results
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / April 23, 2021 /
IM Cannabis Corp. (
Company ) (CSE:IMCC)(NASDAQ:IMCC), a multi-country operator (
IM Cannabis Reports Fiscal 2020 Results; Provides Preliminary Q1 Results and Q2 Outlook phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.